56 related articles for article (PubMed ID: 38719932)
1. Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer.
Kayser A; Wolff A; Berlin P; Duehring L; Henze L; Mundkowski R; Bergmann W; Müller-Hilke B; Wagner C; Huehns M; Oehmcke-Hecht S; Maletzki C
Sci Rep; 2024 May; 14(1):10582. PubMed ID: 38719932
[TBL] [Abstract][Full Text] [Related]
2. KRAS-mutant colorectal cancer cell lines cause a prothrombotic state through the upregulation of thrombin: experimental study.
Xu D; Liao C; Tan J
Ann Med Surg (Lond); 2024 Feb; 86(2):850-855. PubMed ID: 38333285
[TBL] [Abstract][Full Text] [Related]
3. Procoagulant Activity of Blood and Microvesicles Is Disturbed by Pneumococcal Pneumolysin, Which Interacts with Coagulation Factors.
Oehmcke-Hecht S; Maletzki C; Surabhi S; Siemens N; Khaimov V; John LM; Peter SM; Hammerschmidt S; Kreikemeyer B
J Innate Immun; 2023; 15(1):136-152. PubMed ID: 35843205
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles and Transforming Growth Factor β Signaling in Cancer.
Rodrigues-Junior DM; Tsirigoti C; Lim SK; Heldin CH; Moustakas A
Front Cell Dev Biol; 2022; 10():849938. PubMed ID: 35493080
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages.
Yin Y; Liu B; Cao Y; Yao S; Liu Y; Jin G; Qin Y; Chen Y; Cui K; Zhou L; Bian Z; Fei B; Huang S; Huang Z
Adv Sci (Weinh); 2022 Mar; 9(9):2102620. PubMed ID: 35356153
[TBL] [Abstract][Full Text] [Related]
6. One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Oba MS; Kimura T; Ibusuki K; Takita A; Sakon M
Thromb Res; 2022 May; 213():203-213. PubMed ID: 35282898
[TBL] [Abstract][Full Text] [Related]
7. Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence.
Carpintero-Fernández P; Borghesan M; Eleftheriadou O; Pan-Castillo B; Fafián-Labora JA; Mitchell TP; Yuste A; Ogrunc M; Nightingale TD; Mayan M; O'Loghlen A
Cell Death Dis; 2022 Feb; 13(2):163. PubMed ID: 35184131
[TBL] [Abstract][Full Text] [Related]
8. Tisotumab Vedotin: First Approval.
Markham A
Drugs; 2021 Dec; 81(18):2141-2147. PubMed ID: 34748188
[TBL] [Abstract][Full Text] [Related]
9. Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition.
Kumarasamy V; Vail P; Nambiar R; Witkiewicz AK; Knudsen ES
Cancer Res; 2021 Mar; 81(5):1347-1360. PubMed ID: 33323381
[TBL] [Abstract][Full Text] [Related]
10. Elevated Microparticles, Thrombin-antithrombin and VEGF Levels in Colorectal Cancer Patients Undergoing Chemotherapy.
Wojtukiewicz MZ; Mysliwiec M; Sierko E; Sobierska M; Kruszewska J; Lipska A; Radziwon P; Tucker SC; Honn KV
Pathol Oncol Res; 2020 Oct; 26(4):2499-2507. PubMed ID: 32583332
[TBL] [Abstract][Full Text] [Related]
11. Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer.
Kasthuri RS; Hisada Y; Ilich A; Key NS; Mackman N
Res Pract Thromb Haemost; 2020 May; 4(4):636-643. PubMed ID: 32548563
[TBL] [Abstract][Full Text] [Related]
12. The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges.
Loh CY; Chai JY; Tang TF; Wong WF; Sethi G; Shanmugam MK; Chong PP; Looi CY
Cells; 2019 Sep; 8(10):. PubMed ID: 31547193
[TBL] [Abstract][Full Text] [Related]
13. Vincristine induces procoagulant activity of the human lymphoblastic leukemia cell line Jurkat through the release of extracellular vesicles.
Pluchart C; Poitevin G; Colinart-Thomas M; Guimard G; Audonnet S; Terryn C; Nguyen P
J Thromb Thrombolysis; 2019 Aug; 48(2):195-202. PubMed ID: 31175530
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes and Clotting Factors: The Emerging Role of Tumor Cell Genome and Epigenome in Cancer-Associated Thrombosis.
Tawil N; Bassawon R; Rak J
Semin Thromb Hemost; 2019 Jun; 45(4):373-384. PubMed ID: 31096313
[TBL] [Abstract][Full Text] [Related]
15. Targeting Immune-Related Molecules in Cancer Therapy: A Comprehensive
Maletzki C; Scheinpflug P; Witt A; Klar E; Linnebacher M
Biomed Res Int; 2019; 2019():4938285. PubMed ID: 30891459
[TBL] [Abstract][Full Text] [Related]
16. Selected Aspects of Chemoresistance Mechanisms in Colorectal Carcinoma-A Focus on Epithelial-to-Mesenchymal Transition, Autophagy, and Apoptosis.
Skarkova V; Kralova V; Vitovcova B; Rudolf E
Cells; 2019 Mar; 8(3):. PubMed ID: 30871055
[TBL] [Abstract][Full Text] [Related]
17. L1 drives IFN in senescent cells and promotes age-associated inflammation.
De Cecco M; Ito T; Petrashen AP; Elias AE; Skvir NJ; Criscione SW; Caligiana A; Brocculi G; Adney EM; Boeke JD; Le O; Beauséjour C; Ambati J; Ambati K; Simon M; Seluanov A; Gorbunova V; Slagboom PE; Helfand SL; Neretti N; Sedivy JM
Nature; 2019 Feb; 566(7742):73-78. PubMed ID: 30728521
[TBL] [Abstract][Full Text] [Related]
18. Mortality risk analysis of asymptomatic and symptomatic venous thromboembolism in patients with metastatic colorectal cancer.
Bozkaya Y; Özdemir N; Erdem GU; Demirci NS; Yazıcı O; Hocazade C; Zengin N
J Cancer Res Ther; 2018; 14(6):1330-1335. PubMed ID: 30488852
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
